UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] ☒     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2019 September 30, 2020

[   ] ☐     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  __________ to __________

Commission file numberFile No. 333-227350

KELINDA

BANGFU TECHNOLOGY GROUP CO., LTD.

(Exact name of registrant as specified in its charter)

Street: Mihail Kogălniceanu, 66, off. 3

City: Chisinau

ZIP: MD-2009

Country: Republic of Moldova

+373 621-150-42

petru.afanasenco@kelinda.me

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d)15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]☒    No [ ]☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes [ ]☒    No [X]☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B)13(a) of the SecuritiesExchange Act. [ ]☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

: Yes [X]☒    No [ ]☐

State the numberAs of November 13, 2020, there were 7,950,500 shares outstanding of eachcommon stock, par value $0.001, of the issuer's classes of common equity, as of the latest practicable date:  7,950,500 common sharesCompany issued and outstanding as of January 30, 2020.outstanding.

BANGFU TECHNOLOGY GROUP CO., LTD.

Quarterly Report on Form 10-Q

KELINDA

QUARTERLY REPORT ON FORM 10-Q

Table of ContentsTABLE OF CONTENTS

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (the “Report”), including, without limitation, statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our ability to consummate any acquisition or other business combination and any other statements that are not statements of current or historical facts. These statements are based on management’s current expectations, but actual results may differ materially due to various factors, including, but not limited to:

2

The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

PART I –- FINANCIAL INFORMATION

The accompanying interim financial statements of Kelinda (“the Company,” “we,” “us” or “our”)BANGFU TECHNOLOGY GROUP CO., have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted principles have been condensed or omitted pursuant to such rules and regulations.LTD.

CONDENSED BALANCE SHEETS

(Unaudited)

The interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements.

In the opinion of management, the financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

3

The accompanying notes are an integral part of these condensed unaudited financial statements.

BANGFU TECHNOLOGY GROUP CO., LTD.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

4

The accompanying notes are an integral part of these condensed unaudited financial statements.

BANGFU TECHNOLOGY GROUP CO., LTD.

CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

5

The accompanying notes are an integral part of these condensed unaudited financial statements.

BANGFU TECHNOLOGY GROUP CO., LTD.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

6

The accompanying notes are an integral part of these condensed unaudited financial statements.

BANGFU TECHNOLOGY GROUP CO., LTD.

7

KELINDA

NOTES TO THE CONDENSED UNAUDITED FINANCIAL STATEMENTS

FOR THE SIXTHREE MONTHS ENDED DECEMBER 31,SEPTEMBER 30, 2020 AND 2019

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

Kelinda (“the Company,” “we,” “us” or “our”Bangfu Technology Group Co., Ltd. (the “Company”) was incorporated under the name “Kelinda” in the state of Nevada on December 18, 2017 to create health related applications. The Company’s first project was to develop a mobile application (the “App”) to free test panels to identify general health conditions and targeted diseases for both children and adults. The main purpose of the App was to remind users for doctor’s appointments and examinations. The App synchronized with Google and Apple calendars and sent notifications regarding pills-taking time, required tests or doctor appointments via the App and email. The Company expected to generate revenue from in-app subscriptions. Prior to the Change of Control as defined below, the Company had developed terms of reference, design of the App, creation of an Apple store account and was at the server and application development stage.

Pursuant to a Stock Purchase Agreement (the “Agreement”), entered into as of March 16, 2020, by and between Fuming Yang (the “Purchaser”) and Petru Afanasenco, Andrei Afanasenco and Yuriy Turchynskyy, as the representative of certain stockholders (collectively, the “Sellers”) of the Company, the Sellers sold an aggregate of 7,948,000 shares of common stock, par value $0.001 per share, of the Company to the Purchaser in consideration for an aggregate purchase price of $330,000 in cash from the Purchaser’s personal funds (the “Transaction”). Following consummation of the Transaction, the Purchaser holds approximately 99% of the issued and outstanding shares of common stock of the Company. The Transaction resulted in a change in control (“Change in Control”) of the Company from the Sellers to the Purchaser. 

On June 3, 2020, the Company filed a Certificate of Amendment to the Company’s Articles of Incorporation with the Secretary of State of the State of Nevada. The Company specializes on application development with its first project being an application ofNevada to effect a change in the same name Kelinda. It offers panels of various analyses with schedules and reminders about the necessity of visiting doctors sent through the application and emails, as well as storage of personal data (analyses and conclusions). Users may upload them at their discretion and exchange their personal data. Users who download the application can access the lists and data of another user upon receipt of an invitation from the latter. We offer free basic schedules and more serious panels to both adults and children in order to prevent development of numerous diseases. In addition, Kelinda offers drug-taking reminders for an even more effective use of the application. Revenue is to be generated by subscription-based access sales. 

The functional and reporting currency of the Company isfrom “Kelinda” to “Bangfu Technology Group Co., Ltd.”, effective upon filing. In connection with its name change, the US dollar. The Company’s year-end is June 30.ticker symbol on the OTC Pink Market changed from “KLDA” to “BFGX.”

Following this Change in Control, the Company changed its business plan to engage in online business services in the People’s Republic of China. The Company plans to engage in developments of personal daily life assistance mobile applications, online educational trainings, and employment recruitment services in China. The Company plans to roll out the plan with a focus in the tier-3 and tier-4 cities in the provinces of Guangdong and Guangxi first. The Company is presently evaluating the optimal corporate and legal structures in China necessary to establish and implement these business plans. The Company aims to start implementing these business plans in 2020 but its ability to execute on its business plans and initiatives will depend upon the developments of the pandemic, including the duration and spread of the COVID-19 and lockdown restrictions imposed by the respective various governments and oversight bodies in China.

NOTE 2 – GOING CONCERN

The accompanying financial statements have been prepared in conformity with United States generally accepted accounting principles, which contemplate continuation of the Company as a going concern. As a start-up, the Company has had no revenues and has accumulated losses through December 31, 2019.September 30, 2020. The Company currently has limited working capital and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of management’s efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The accompanyingCompany’s unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”(“U.S. GAAP”), including the instructions to Form 10-Q and Regulation S-X and. The accompanying unaudited condensed financial statements reflect all adjustments, consisting of only normal recurring adjustments,items, which, in the opinion of management, believes are necessary to fairly presentfor a fair statement of the financial position, results of operations and cash flows of the Company for the six month period ended December 31, 2019. Although management believes the disclosuresperiods shown and information presented are adequate to make the information not misleading, it is suggested that these interim financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its Form 10-K for the year ended June 30, 2019. Operating results for the six months ended December 31, 2019 are not necessarily indicative of the results to be expected for the full year ending June 30, 2021. These unaudited condensed financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2020.

The functional and reporting currency of the Company is the U.S. dollar.

Cash and Cash Equivalents

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. The Company had $89 and $412 ofno cash or equivalents as of December 31, 2019 andSeptember 30, 2020 or June 30, 2019, respectively,2020.

Taxation

Current income taxes are provided on the basis of net profit for financial reporting purposes, adjusted for income and no cash equivalents.expense items which are not assessable or deductible for income tax purposes, in accordance with the regulations of the relevant tax jurisdictions.

Income Taxes

IncomeDeferred income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on therecognized for temporary differences between the financial reporting and tax bases of assets and liabilities and their reported amounts in the consolidated financial statements, net operating loss carry forwards and credits. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided in accordance with the laws of the relevant taxing authorities. Deferred tax assets and liabilities are measured using the currently enacted rates expected to apply to taxable income in which temporary differences are expected to be reversed or settled. The effect on deferred tax assets and liabilities of changes in tax rates is recognized in the statement of comprehensive income in the period of the enactment of the change.

The Company considers positive and laws. A valuation allowance is provided fornegative evidence when determining whether a portion or all of its deferred tax assets will more likely than not be realized. This assessment considers, among other matters, the amountnature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of statutory carry-forward periods, its experience with tax attributes expiring unused, and its tax planning strategies. The ultimate realization of deferred tax assets that, based on available evidence, are notis dependent upon its ability to generate sufficient future taxable income within the carry-forward periods provided for in the tax law and during the periods in which the temporary differences become deductible. When assessing the realization of deferred tax assets, the Company has considered possible sources of taxable income including (i) future reversals of existing taxable temporary differences, (ii) future taxable income exclusive of reversing temporary differences and carry-forwards, (iii) future taxable income arising from implementing tax planning strategies, and (iv) specific known trend of profits expected to be realized.

                                                                                                                                                                      8

KELINDA

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019

Application Development Costsreflected within the industry.

The Company followsrecognizes a tax benefit associated with an uncertain tax position when, in its judgment, it is more likely than not that the provisionsposition will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of ASC 985, “Software,” which requires that all costs relatingbeing realized upon ultimate settlement with a taxing authority. The Company’s liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the purchaseprogress of tax audits, case law developments and new or internal development and production of software products to be sold, leased or otherwise marketed, be expensedemerging legislation. Such adjustments are recognized entirely in the period incurred unlessin which they are identified. The Company’s effective tax rate includes the requirementsnet impact of changes in the liability for technological feasibility have been established.unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company capitalizes all eligible software costs incurred once technological feasibility is established. The Company amortizes these costs usingclassifies interest and penalties recognized on the straight-line method over a period ofliability for unrecognized tax benefits as income tax expense.

There were no current and future income tax provision recorded for the three years, which is the remaining estimated economic life of the costs. At the end of each reporting period,months ended September 30, 2020 or 2019 since the Company writes downdid not generate any excess of the unamortized balance over the net realizable value.   revenues in these periods.

Equipment

Equipment is stated at cost, net of accumulated depreciation. The cost of equipment is depreciated using the straight-line method. We estimate that the useful life of equipment is 5 years Expenditures for maintenance and repairs are charged to expense as incurred. Additions, major renewals and replacements that increase the equipment'sequipment’s useful life are capitalized. Equipment sold or retired, together with the related accumulated depreciation is removed from the appropriated accounts and the resultant gain or loss is included in net income.

Use of Estimates

The preparation of financial statements in conformity with United States generally accepted accounting principlesU.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Basic Income (Loss) Per Share

The Company computes income (loss) per share in accordance with FASB ASC 260 “Earnings per Share.” Basic loss per share is computed by dividing net income (loss) available to common shareholdersstockholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is antidilutive. There were no potentially dilutive debt or equity instruments issued or outstanding as of December 31, 2019 andSeptember 30, 2020 or June 30, 2019.2020.

Recent Accounting Pronouncements

We haveThe Company has reviewed all the recently-issued,recently issued, but not yet effective, accounting pronouncements and we dodoes not believe any of these pronouncements will have a material impact on the Company.

NOTE 4 – STOCKHOLDERS’ EQUITY

The Company has 75,000,000 $0.001 par valueauthorized shares of common stock, authorized. On March 19, 2018, the Company issued 4,000,000 founders’ shares of common stock to the President, Petru Afanasenco, and, on March 20, 2018, the Company issued 3,000,000 founders’shares of common stock to the Secretary, Andrei Afanasenco, for cash contributions of $4,000 and $3,000 at $0.001 per share, respectively.

During March 2019, the Company issued 195,000 shares of common stock for cash proceeds of $5,850 at $0.03par value per share.

During April 2019, the Company issued 547,500 shares of common stock for cash proceeds of $16,425 at $0.03 per share.

During May 2019, the Company issued 208,000 shares of common stock for cash proceeds of $6,240 at $0.03 per share.

There were 7,950,500no shares of common stock issued and outstanding as of December 31, 2019 and Juneduring the three months ended September 30, 2020 or 2019.

9

KELINDA

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED DECEMBER 31, 2019

NOTE 5 – RELATED PARTY TRANSACTIONS

During the sixthree months ended December 31,September 30, 2020 and 2019, and 2018, the former President of the Company, Petru Afanasenco, loaned to the Company $44,888nil and $0,$15,750, respectively.

During the sixthree months ended December 31,September 30, 2020 and 2019, and 2018, the Company’s officer,former Treasurer and Secretary, Andrei Afanasenco, loaned to the Company $5,800nil and $8,715,$2,850, respectively.

As of December 31, 2019 and June 30, 2019,On March 16, 2020, in connection with the balance due to the Company’s officers was $83,903 and $33,215 respectively.Change in Control, Petru Afanasenco and Andrei Afanasenco have formal commitmentsentered into debt forgiveness agreements pursuant to loan fundswhich the two related parties forgave loans in the total amount of $50,000$83,903 that the Company owed to them. These forgiven loans were treated as capital contributions from the Company’s related parties and $40,000, respectively. These loans are unsecured, non-interest bearingtherefore a total gain of $83,903 was recorded in equity. 

During the three months ended September 30, 2020, the Company’s principal stockholder and due on demand.sole officer and director, Fuming Yang, contributed $17,750 to the Company for working capital use.

NOTE 6 – COMMITMENTS AND CONTINGENCIES

On August 21, 2019, the Company entered into a new rental agreement for use of an address, office facilities, IT and telecommunication systems, office equipment and secretarial services.  The contract is $73 per month and is entered into for a month to month-term.  

NOTE 7 – INTANGIBLE ASSETS

As of June 30, 2019, the unamortized balance of the Application Development Costs related to the purchase or internal development and production of software to be sold, leased, or otherwise marketed was $98,870.  During the six months ended December 31, 2019, the Company recorded amortization expense of $16,478, resulting in an unamortized balance of $82,392 at December 31, 2019. No impairment was recorded during the period, as the December 31, 2019 unamortized balance is deemed to be equal to the net realizable value. As of December 31, 2019, the total amount of accumulated amortization was $16,478.

The amortization expenses of the application development costs for the next three years are set for the below:Company presently has no material commitments and contingencies.

NOTE 87 – SUBSEQUENT EVENTS

In accordance with ASC 855, “Subsequent Events,” the Company has analyzed its operations subsequent to December 31, 2019,September 30, 2020, through the date thewhen financial statements were issued, and has determined that it does not have any material subsequent events to disclose.disclose in these financial statements.

10

Forward looking statement notice

Statements made in this Form 10-Q that are not historical or current facts are "forward-looking statements" made pursuant to the safe harbor provisionsThe following discussion and analysis of Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management's best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and eventsfinancial condition should be read together with our unaudited financial statements and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

Financial information containednotes thereto, which are included elsewhere in this quarterly reportReport and in our unaudited interimAnnual Report on Form 10-K for the year ended June 30, 2020 (the “Annual Report”) filed with SEC. Our financial statements is stated in United States dollars and arehave been prepared in accordance with United States generally accepted accounting principles.principles in the United States (the “U.S. GAAP”).

DESCRIPTION OF BUSINESSOverview

OurThe Company

Kelinda is a start-up company that was establishedincorporated under the name “Kelinda” in the state of Nevada on December 18, 2017. Its2017 to create health related applications.

Following a Change in Control on March 16, 2020, the Company changed its business plan to engage in online business service in the People’s Republic of China. The Company changed its name to Bangfu Technology Group Co., Ltd. on June 3, 2020 and its stock ticker to “BFGX”, effective June 8, 2020.

Results of Operations

Revenue

For the three months ended September 30, 2020 and 2019, the Company did not generate any revenue. The Company does not expect to generate revenue until its business plan is implemented.

Operating Expenses

Total operating expenses for the three months ended September 30, 2020 were $17,750, an increase of 26% as compared to create health-caring applications. Kelinda is bothoperating expenses of $14,113 for the namesame period of 2019. The operating expenses for the three months ended September 30, 2020 primarily included audit expense, legal fees and professional fees , whereas for the same period of 2019, the operating expenses primarily included professional fees and depreciation expenses. The increase was primarily due to increase in legal expenses since the Company now engaged a legal counsel to assist with the Company’s periodic filings, whereas in 2019, there were no such similar services.

Net Loss

As a result of the company andforegoing, the first product that this company will be launching. All future products will be launched under this company but with different names to reflect the target market.  Our first project will offer free test panels to identify general health conditions and targeted diseasesCompany incurred a net loss of $17,750 for both children and adults. Its main purpose will be to inform individuals when it is required for a person to visit certain doctors and get tested in order to prevent disease development on its earliest development stage. The App will synchronize with Google and Apple calendars, send notifications regarding pills-taking time, required tests or doctor appointments via the App and email. In the future, the revenue shall be generated from in-app subscriptions. As of today, we have developed terms of reference, design of our application, creation of an Apple store account and, currently find ourselves at the server and application development stage. It is anticipated that the app can be completed and operational in about 3 months, available on AppStore and PlayMarket. In the event that the full proceeds of the offering are not raised, the timing of the rollout will be slowed.

Our Application

An average man has only a limited knowledge about diseases, their various symptoms and, therefore, some are discovered at their late phases of development. Research has shown that the top three causes of death in the United States are linked to health conditions. They are heart disease (23.4% of all deaths), cancer (22.5%) and chronic lower respiratory disease (5.6%) and the three of them account for over 50 percent of all deaths. Other death causes are stroke (5.1% of all deaths), diabetes (2.9%), Influenza and pneumonia (2.1%) and kidney disease (1.8%). A substantial proportion of these diseases could be prevented by regular health check-ups, monitoring of health condition patterns and on-time pills/injections taking.

“Kelinda” is a subscription-based multi-lingual mobile application that provides comprehensive health lab test panels and pill-taking reminders for children and adults and a truly outstanding tool to saving lives.

“My Account” tab displays selected panels, check-ups and pill taking lists that a user may opt to undertake. These panels may be added from the Panels tab on the Main Menu.

“Panels” tab demonstrates a list of various check-up panels with detailed user information on what they are, frequency of health screenings, and impact to preventing numerous diseases, etc. Each panel consists of a list of consultations, analyses and tests. These panels are also arranged by categories: “Disease” (if a person has a predispositionmonths ended September 30, 2020, as compared to a disease, he adds one outnet loss of $14,113 for the presented panels to personal check-up calendar). A user may alternatively choose to undertake only a specific analysis from “Analyzes” tab.

11

“Recommendations” general panels which should be held on a monthly/yearly/5-year/10-year basis by everyone as well as advised panels corresponding specified age and age group, sex and BMI of a user.

Users can create personal visit schedules and enable/disable notifications about the upcoming events. The reminders come up as in-app pop-ups and gentle reminders to the user’s email address. Alternatively, users may use the default schedules of selected panels, whereas a user determines an exact start date by creating an entry to the calendar. The schedules of the application are automatically synched with Apple Calendar and / or Google Calendar.

The application allows users to store personal data, such as test results and doctors’ conclusions and prescriptions. All such information may be uploaded at users’ individual discretion. “Kelinda” empowers data exchange between users upon acceptance of such allowance. Initially, personal data is only available for viewing and not for downloading nor screenshotting.

“Kelinda” is a great reminding tool. The app lets you create multiple reminders for multiple medications and doctor appointments and includes a repeat function along with notification reminders.

After downloading the mobile application from a market (iOS or Android), the user is provided an opportunity to use the application for free forthree months ended September 30, calendar days. After the expiration date, users are offered to sign up for a paid subscription.

The success of this app will rest on providing the end-user trustworthy and useful information. One of the innovative features of this app is that it will allow users to find health panels that prevent particular diseases, upload and share documents with doctors and friends, and will provide useful information about our health in general. It is hoped that these features, along with the clean and easy to use user interface will propel “Kelinda” to the head of the growing health app market.

The success of this app will rest on providing the end-user trustworthy and useful information. One of the innovative features of this app is that it will allow users to find health panels that prevent particular diseases, upload and share documents with doctors and friends, and will provide useful information about our health in general. It is hoped that these features, along with the clean and easy to use user interface will propel “Kelinda” to the head of the growing health app market.

Competition

We expect to face strong competition from the on Med-Care Application industry that nowadays is rapidly developing, and which popularity is continuously growing. The most competitive service provider is MediSafe that is intended to be used by patients who are on prescription medications for a medical diagnosis and that has been selected as one of Healthline’s Best Bipolar Apps of 2018. Though this company is well-known, it is limited to providing pills reminders, whereas “Kelinda” not only will remind users to take their medications but will additionally allow users to find health panels that prevent development of particular diseases, upload and share documents with doctors and friends, and will provide useful information about their health in general. These points are positioned to be our strengths and opportunities over any competition we might currently face.

Revenue

The Company’s revenue is to be generated from in-app subscriptions. Additionally, we might consider selling the advertising slots for in-app advertising to other applications.

Employees Identification of Certain Significant Employees.

We are a start-up company and currently have two employees – Petru and Andrei Afanasenco.

Petru Afanasenco – President and Director, who is in charge of the core business processes and its financials.

Andrei Afanasenco – Chair, Secretary and Treasurer, who is in charge of day-to-day business processes, App development and PR.  

We intend to outsource any additional services if the business requires so.

The Office

Our executive office is located at 49/3 Tighina street 54, Chisinau, Moldova, MD-2001. Our telephone number is +373 621-150-42.

12

2019.

Government Regulation

We will be required to comply with all regulations, rules, and directives of governmental authorities including the US Securities and Exchange Commission and agencies applicable to our business in any jurisdiction with which we would conduct activities. As a smaller reporting company, we may face an effect of existing or probable governmental regulations on the business, Item 101(h)(4)(ix) of Regulation S-K. Due to the specifics of the business, Kelinda shall comply to the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") regulations and may face an impact on users allowance to upload and store personal health data.

Legal Proceedings

During the past ten years, none of the following occurred with respect to the Board of Directors of the Company: (1) any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time; (2) any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses); (3) being subject to any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of any competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting her involvement in any type of business, securities or banking activities; and (4) being found by a court of competent jurisdiction (in a civil action), the SEC or the commodities futures trading commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended or vacated.

We are not currently a party to any legal proceedings, and we are not aware of any pending or potential legal actions.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This quarterly report contains certain forward-looking statements and our future operating results could differ materially from those discussed herein. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions of the forward -looking statements contained herein to reflect future events or developments.

Our Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act

Our Company shall continue to be deemed an emerging growth company until the earliest of—

1.The last day of the fiscal year of the issuer during which it had total annual gross revenues of $1,000,000 (as such amount is indexed for inflation every 5 years by the Commission to reflect the change in the Consumer Price Index for All Urban Consumers, published by the Bureau of Labor Statistics, setting the threshold to the nearest $1,000,000) or more; 

2.Its total annual gross revenues are $1.07 billion or more; 

3.The last day of the fiscal year of the issuer following the fifth anniversary of the date of the first sale of common equity securities of the issuer pursuant to an effective registration statement under this title’; 

4.The date on which such issuer has, during the previous 3-year period, issued more than $1,000,000 in non-convertible debt; or 

5.The date on which such issuer is deemed to be a ‘large accelerated filer’, as defined in section 240. 12b-2 of title 17, Code of Federal Regulations, or any successor thereto.’ 

Pursuant to the Rule 405 of the Securities Act of 1933, the Company would cease to be an emerging growth company if it has more than $1.0 billion in annual revenues, its total annual gross revenues are $1.07 billion or more, or issues more than $1.0 billion of non-convertible debt over a three-year period.

As an emerging growth company, Kelinda is exempt from Section 404(b) of Sarbanes Oxley. Section 404(a) requires Issuers to publish information in their annual reports concerning the scope and adequacy of the internal control structure and procedures for financial reporting. This statement shall also assess the effectiveness of such internal controls and procedures. 

13

Section 404(b) requires that the registered accounting firm shall, in the same report, attest to and report on the assessment on effectiveness of the internal control structure and procedures for financial reporting.

As an emerging growth company, the company is exempt from Section 14A and B of the Securities Exchange Act of 1934 which require shareholder approval of executive compensation and golden parachutes.

In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period.

Going Concern

The future of our company is dependent upon itsour ability to obtain financing to implement our new business plans and upon future profitable operationsinitiatives and our ability to generate positive net profits from the saleimplementation of products and services through our website and application.business plans. Management has plans to seek additional capital funding through a private placementeither equity financings or debt financings from its principal stockholders to support its operations for the next twelve months. However, there is no assurance that such funds will be available or available on acceptable terms. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and public offering of its common stock, if necessary. Our auditors have expressed a going concern opinion which raises substantial doubts aboutmaterially restrict our ability to continue as a going concern.business operations.

Liquidity and capital resourcesCapital Resources

As of December 31, 2019,September 30, 2020, the Company had $83,793 in total assets. Theseno assets, are in cash of $89, fixed assets of $1,312no liabilities and intangible assets of $82,392. As of June 30, 2019, the Company had $100,792 in total assets.

As of December 31, 2019, the Company had $103,003 in liabilities and an accumulated deficit of $54,725. As of June 30, 2019, the Company had $86,365 in liabilities and an accumulated deficit of $21,088.$167,778.

CASH FLOWS FROM OPERATING ACTIVITIESCash Flows from Operating Activities

For the sixthree months period ended December 31, 2019,September 30, 2020, net cash flows used in operating activities was $(51,011). Net$17,750, which is due to the net loss for the period of $17,750.

For the three months ended September 30, 2019, net cash used in operating activities was $18,898, which is primarily the result of: (1) net loss for the six months period ended December 31, 2018, was $(7,466).of $14,113; (2) adjustment for depreciation of $8,338; and (3) adjustment for decrease in accounts payable of $13,050. 

CASH FLOWS FROM FINANCING ACTIVITIESCash Flows from Financing Activities

For the sixthree months period ended December 31, 2019,September 30, 2020, net cash flows generated by financing activities was $50,688. Cash flows$17,750, which represented capital contribution from the Company’s principal stockholder to support the operations of the Company. For the three months ended September 30, 2019, net cash generated by financing activities forwas $18,600, which represented advances from related party to support the six months period ended December 31, 2018, was $8,715.  Our financing activities are comprised of loans from our management.Company’s operations.

Material commitments

We havehad no material commitments for the next twelve months. We will however require additional capital to meet our liquidity needs.as of September 30, 2020.  

Results of Operations

For the three- and six-months period ended December 31, 2019 and 2018, the Company did not generate any revenue.

Our net losses for the six months ended December 31, 2019 and 2018 were $33,637 and $8,388, respectively.

OPERATING EXPENSES

Total operating expenses for the six months ended December 31, 2019 and 2018 were $33,637 and $8,388. The operating expenses for the six months ended December 31, 2019 included audit fees of $5,200; bank charges of $215; amortization and depreciation expense of $16,676; legal fees of $765; miscellaneous expense of $91; professional fees of $10,479; rent expense of $211. The operating expenses for the six months ended December 31, 2018 included audit fees of $4,500; bank charges of $341; depreciation expense of $197; legal fees of $3,065; miscellaneous expense of $15; rent expense of $270.

14

The increase in operation expenses is mainly due to the higher amortization expense, as the Company released its mobile application at the end of June 2019.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial statementscondition and accompanying notes have been prepared in accordance with United States generally accepted accounting principles appliedresults of operations is based on a consistent basis. The preparation ofour financial statements. In preparing our financial statements in conformity with U.S. generally accepted accounting principles requires management toGAAP, we must make a variety of estimates and assumptions that affect the reported amounts and related disclosures. See Note 3 of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

We regularly evaluate the accounting policies and estimates that we use to prepare our interim financial statements.  In general, management’s estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.

In addition, Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.

NoneNot applicable.

Our management is responsible for establishing and maintaining a system of disclosureDisclosure controls and procedures (as defined in Rule 13a-15(e)are controls and 15d-15(e) under the Exchange Act)other procedures that isare designed to ensure that information required to be disclosed by us in theour reports that we filefiled or submitsubmitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’sSEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in thecompany reports that it filesfiled or submitssubmitted under the Exchange Act is accumulated and communicated to the issuer’s management, including itsour principal executive officer or officers and principal financial officer, or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conductedAs required by Rules 13a-15 and 15d-15 under the supervisionExchange Act, our principal executive officer and with the participation of our managementprincipal financial officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2019.September 30, 2020. Based on thatupon their evaluation, our managementprincipal executive officer and principal financial officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of such datedue to ensure that information requiredthe material weakness identified below due to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.our limited resources:

Changes in Internal ControlsControl over Financial Reporting

There was no changehave not been any changes in the Company’sour internal controlcontrols over financial reporting that occurred during the quarterly period covered by this reportour fiscal quarter ended September 30, 2020 that hashave materially affected, or isare reasonably likely to materially affect, the Company’sour internal control over financial reporting.

PART II - OTHER INFORMATION

                                                                                                                                                                    15

PART II.  OTHER INFORMATION

We are not involved in any pending legal proceeding nor are we aware of any pending or threatened litigation against us.None.

NoneNot applicable

NoneNone.

NoneNone.

NoneNot applicable.

NoneNone.

The following exhibits are includedfiled as part of, or incorporated by reference into, this report by reference:Quarterly Report.

SIGNATURES

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1933, as amended,1934, the registrant has duly caused this registration statementreport to be signed on its behalf by the undersigned, thereunto duly authorized in the city of Chisinau, Republic of Moldova on February 4, 2020.authorized.

16